Biotechnology News

September 11, 2012

TORONTO--(BUSINESS WIRE)--GUAVA II will Enable ECG Triaging of CardioComm Solutions Wireless and Internet Based GEMS, GlobalCardio, C4 and SMART Monitoring ECG Management Solutions

September 11, 2012

CARY, N.C.--(BUSINESS WIRE)--Industry Standard Research (ISR) released "Improving Patient Recruitment in Biosimilar Trials" a novel and comprehensive market research report examining recruitment in Biosimilar clinical trials.

September 11, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Cold Genesys Announces SPA Agreement with FDA on a Phase 2/3 Pivotal Trial of CG0070 as an Intravesical Treatment for Non-Muscle Invasive Bladder Cancer patients after BCG failure

September 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study finds that although less than half of surveyed companies report using MSLs in payer presentations, the significant percentage that do marks a growing trend among MSL teams.

September 11, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM) (the “Company”), a developer of bioactive peptides, today announced that it has filed a Schedule 13E-3 and related preliminary proxy statement with the Securities and Exchange...

September 11, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Transition to Commercialization Means BioFuel and Plant Oil Producers Now Able to Purchase Commercial Quantities of Lipid-Enhancing Product

September 11, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Parkinson's disease lead researcher Dr. Patrizia Fanara presents ground-breaking data at neurodegeneration conference showing how isotopic labeling is advancing earlier diagnosis and treatment

September 11, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced the final results of its modified Dutch auction...

September 11, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions announced that Chairman and CEO Tarek Sherif, President Glen de Vries, and Chief Financial Office Cory Douglas will participate in three upcoming investor conferences in September.

September 11, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus has entered into independent partnership agreements with American Red Cross and Blood Systems Incorporated to commercialize INTERCEPT plasma for use in the orphan indication of TTP.

September 11, 2012

SAN DIEGO--(BUSINESS WIRE)--At this week’s CAP ’12 annual conference of the College of American Pathologists, DR Systems is demonstrating its Unity™ enterprise imaging solution for pathology.

September 11, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the World Health Organization (WHO) has granted an expansion to the prequalification of Pfizer’s pneumococcal conjugate vaccine, Prevenar 131 (Pneumococcal polysaccharide...

September 11, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Company executives will not be presenting at the following...

September 11, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Covidien announced that it has received 510(k) clearance from the U.S. FDA for the LigaSure™ curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat procedures.

September 11, 2012

STOCKHOLM--(BUSINESS WIRE)--GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]...

September 11, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the appointment...

September 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra Inc. has appointed Donna M. Ambrosino, M.D., as chief medical officer.

September 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc. has entered into a collaboration agreement with Pfizer to discover novel antibodies using Visterra’s proprietary platform.

September 11, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the UBS Global Life Sciences Conference on Thursday, September 20th , 2012, at 8:30 a.m. Eastern Daylight Time at the Grand Hyatt New...

September 11, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the introduction of its rapid Individual Genome Sequencing (IGS) service with a turnaround time in as little as two weeks. Rapid turnaround whole genome sequencing services...

September 11, 2012

PARIS--(BUSINESS WIRE)--Exonhit – Half-year 2012 results

September 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced several business updates. The...

September 11, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics President and CEO Andrew Krouse will share his expertise in repositioning T-type calcium channel inhibitors for the treatment of solid tumors at the World Drug Repositioning Congress

September 11, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--Projected Growth in $3 Billion Parkinson’s Treatment Market Gives RBCC a Bright Outlook

September 11, 2012

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and the leader in adaptive clinical trial design, simulation and execution, is proud to announce that Dr. Scott Gottlieb has...

September 11, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. priced today a $2.5 billion public offering of senior unsecured notes. The notes include: $1.0 billion of 1.100% notes due 2018 $1.0 billion of 2.400% notes due 2022 $500.0 million...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that Arthur J. Coury, PhD...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra presents preclinical results that show 100% prevention and treatment of influenza with VIS410, a novel engineered human antibody, in an oral presentation at ICAAC in San Francisco, CA.

September 10, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization’s (BIO) 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature two breakout sessions focusing on commercial applications for algae and advances in algal...

September 10, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus MI Holdings, Inc., parent company of Lantheus Medical Imaging, Inc. (the “Company”), a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today...

September 10, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) Receives Complete Response Letter (CRL)from FDA for Lymphoseek® NDA Due to Manufacturing Deficiencies: CRL Unrelated to Lymphoseek® Efficacy and Safety Data

September 10, 2012

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The robust program at BioPharm America™ this year will feature executives from big pharma including Alexion Pharmaceuticals, Amgen, AstraZeneca, Bayer HealthCare, Bristol-Myers...

September 10, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT is pleased to announce that Eduardo De Sousa, M.D., of the University of Oklahoma Health Sciences Center, has been named the recipient of the inaugural 2012 Plasma Exchange Innovation Award

September 10, 2012

SEATTLE--(BUSINESS WIRE)--Theraclone Sciences presents full Phase 1 data of TCN-032 for the treatment of influenza A at ICAAC 2012.

September 10, 2012

SADDLE BROOK, N.J.& AACHEN, Germany--(BUSINESS WIRE)--CircuLite has presented positive data on the SYNERGY Circulatory Support System, in which the system was shown to improve hemodynamics, exercise capacity, and overall quality of life.

September 10, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has avoided an interruption in US supply of Increlex® (IGF-1) for the treatment of Severe Primary IGF-1 Deficiency due to delays in manufacturing...

September 10, 2012

SHANGHAI--(BUSINESS WIRE)--Sidley Austin LLP is pleased to announce that Dr. Ling Su, a non-lawyer who is a seasoned drug development professional, has joined the firm as a Strategic Advisor in its China Life Sciences practice. He will draw from...

September 10, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS)(Paris:ALCLS), the French genome engineering specialist, proudly announces the publication of a collaborative paper in Nature Methods1, one of the most prestigious journals for...

September 10, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Osmotica Pharmaceutical Corp. today announced the appointment of Darren Alkins as Executive Vice President. Forrest Waldon, CEO of Osmotica Pharmaceutical stated, “We are pleased to announce that Darren Alkins...

September 10, 2012

WAKEFIELD, Mass.--(BUSINESS WIRE)--Sciessent Announces a Recent Clinical Study that Points to Success in Reducing Catheter Related Bloodstream Infections

September 10, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century to Present on Promising Low Tar-to-Nicotine Ratio Cigarettes; Dr. Gio Batta Gori, Author of Virtually Safe Cigarettes, to Speak at 22nd Century Group Annual Shareholder Meeting

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Annovation Biopharma funded to innovate in anesthesiology

September 10, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio announced it will present data from two preclinical studies at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting currently underway in San Francisco.

September 10, 2012

VIENNA--(BUSINESS WIRE)--Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics...

September 10, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin Hires New CEO Steve Aselage

September 10, 2012

BOSTON--(BUSINESS WIRE)--Immunetics, Inc., has received a $3.7 million, two year SBIR contract from the National Institutes of Health (NIH), to support clinical trials of a new blood screening test for Babesia infection.

September 10, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NeoChord completes enrollment for ‘TACT’ clinical trial

September 10, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medicals’ Seraph™ Microbind™ Affinity Blood Filter demonstrates potential for reducing high death rate from sepsis, a top-10 cause of death in the U.S.

September 10, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Parkinson's researchers make important progress in the search for a Parkinson’s disease biomarker, which could in the future play a critical role in the development of novel therapies